ARVN
Price
$9.52
Change
-$0.16 (-1.65%)
Updated
Oct 17 closing price
Capitalization
698.94M
23 days until earnings call
CMPX
Price
$4.26
Change
-$0.26 (-5.75%)
Updated
Oct 17 closing price
Capitalization
730.9M
18 days until earnings call
Interact to see
Advertisement

ARVN vs CMPX

Header iconARVN vs CMPX Comparison
Open Charts ARVN vs CMPXBanner chart's image
Arvinas
Price$9.52
Change-$0.16 (-1.65%)
Volume$1.95M
Capitalization698.94M
Compass Therapeutics
Price$4.26
Change-$0.26 (-5.75%)
Volume$1.84M
Capitalization730.9M
ARVN vs CMPX Comparison Chart in %
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. CMPX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and CMPX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (ARVN: $9.52 vs. CMPX: $4.26)
Brand notoriety: ARVN and CMPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 96% vs. CMPX: 117%
Market capitalization -- ARVN: $698.94M vs. CMPX: $730.9M
ARVN [@Biotechnology] is valued at $698.94M. CMPX’s [@Biotechnology] market capitalization is $730.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileCMPX’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • CMPX’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 3 TA indicator(s) are bullish while CMPX’s TA Score has 4 bullish TA indicator(s).

  • ARVN’s TA Score: 3 bullish, 5 bearish.
  • CMPX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CMPX is a better buy in the short-term than ARVN.

Price Growth

ARVN (@Biotechnology) experienced а +0.63% price change this week, while CMPX (@Biotechnology) price change was +0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

ARVN is expected to report earnings on Nov 11, 2025.

CMPX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMPX($731M) and ARVN($699M) have the same market capitalization . CMPX YTD gains are higher at: 193.793 vs. ARVN (-50.339). CMPX has higher annual earnings (EBITDA): -66.29M vs. ARVN (-112.6M). ARVN has more cash in the bank: 861M vs. CMPX (101M). ARVN (9.9M) and CMPX (9.9M) have identical debt. ARVN has higher revenues than CMPX: ARVN (373M) vs CMPX (0).
ARVNCMPXARVN / CMPX
Capitalization699M731M96%
EBITDA-112.6M-66.29M170%
Gain YTD-50.339193.793-26%
P/E RatioN/AN/A-
Revenue373M0-
Total Cash861M101M852%
Total Debt9.9M9.9M100%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNCMPX
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 5 days ago
89%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UUPSX75.490.42
+0.56%
ProFunds UltraEmerging Markets Svc
TVLYX12.830.07
+0.55%
Touchstone Value Y
TEMLX10.140.03
+0.30%
Nuveen Emerging Markets Eq R6
TILWX32.560.09
+0.28%
Nuveen Large Cap Growth W
MMKBX26.43N/A
N/A
Morgan Stanley Inst Emerging Mkts A

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VIR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-5.75%
VIR - CMPX
38%
Loosely correlated
-0.34%
VCYT - CMPX
37%
Loosely correlated
+0.06%
ARVN - CMPX
33%
Loosely correlated
-1.65%
CPRX - CMPX
32%
Poorly correlated
+0.10%
RXRX - CMPX
32%
Poorly correlated
-7.86%
More